Clinical Trials Directory

Trials / Completed

CompletedNCT01887704

Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion

Effect of Rotational Atherectomy on Balloon-resistant Calcified Coronary Lesion the During a Long-term Follow-up Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The optimal treatment of calcified coronary lesion remained to be elucidated. A Prospective, randomized controlled trial was perform to explore the immediate effect and long-term outcome of rotational atherectomy in patients with balloon resistant coronary lesion.

Detailed description

The inclusion criteria included patients presenting drug-resistant angina pectoris who underwent balloon resistant angioplasty. The exclusion criteria included: 1. Acute myocardial infarction within the 28 days; 2. Intolerance to aspirin, clopidogrel, contrast media, or statins; 3. Angiographic visible thrombus, or dissection; 4. Left ventricular ejection fraction (LVEF)\<35%; 5. Any type of cancer 6. Hemorrhagic stroke

Conditions

Interventions

TypeNameDescription
DEVICERotablatorRotablator, Boston Scientific, Maple Grove, MN, USA. Rotablator will be used in the Rotablator arm.
PROCEDUREconventional angioplastyConventional angioplasty was used in both arms.
PROCEDUREstentingStenting was implanted in both arms.
DEVICECutting balloonFlextome cutting balloon(Boston Scientific, Natick, MA, USA) was used in both arms.
DRUGAspirinAspirin will be administrated in participants in both arms.
DRUGClopidogrelClopidogrel will be administrated to participants in both arms.
DEVICEPaclitaxel-eluting stentPaclitaxel-eluting stent will be used in both arms.
DEVICEzotarolimus-eluting stentZotarolimus-eluting stent will be implanted in participants in both arms.
DEVICEEverolimus-eluting stentEverolimus-eluting stent will be used in both arms.
DEVICESirolimus-eluting stentSirolimus-eluting stent will be used in both arms.

Timeline

Start date
2010-01-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2013-06-27
Last updated
2013-06-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01887704. Inclusion in this directory is not an endorsement.